Internationally Recognized Breast and Lung Cancer Expert Mohammad
Jahanzeb, M.D., Joins Aptium Oncology Network as Medical Director for
Lynn Cancer Institute West Campus of Boca Raton Community Hospital
LOS ANGELES (Business Wire EON/PRWEB ) July 28, 2008 --
Mohammad Jahanzeb, M.D., F.A.C.P., an internationally recognized expert
in the multidisciplinary management of breast and lung cancer, has
joined the Aptium Oncology network as National Program Director, Care
Guidelines, and Medical Director at the Lynn Cancer Institute West
Campus of Boca Raton Community Hospital in Boca Raton, Florida.
Dr. Jahanzeb, who has focused his medical oncology practice on breast
and lung cancers since 1995, will oversee Lynn Cancer Institute West
Campus’ multidisciplinary programs for breast
and lung cancer patients and help facilitate the launch of additional
clinical programs. Most recently, Dr. Jahanzeb served as the Van Fleet
Endowed Professor in Medical Oncology, Chief of the Division of
Hematology/Oncology and Fellowship Program Director at the University of
Tennessee Health Science Center, as well as the Research Director at the
University of Tennessee Cancer Institute.
“Dr. Jahanzeb’s
international stature, combined with his knowledge and expertise in
breast and lung cancers, will be tremendous assets to Lynn Cancer
Institute West Campus of Boca Raton Community Hospital in taking our
treatment programs to the next level,” said
John S. Macdonald, M.D., Chief Medical Officer, Aptium Oncology. “As
a distinguished leader in the treatment and research of breast and lung
cancers, Dr. Jahanzeb will play an important role in advancing Aptium’s
commitment to comprehensive cancer services and patient care of the
highest quality.”
A highly respected practitioner, lecturer and researcher, Dr. Jahanzeb
has authored or contributed to more than 100 original reports and
abstracts on breast and lung cancer. These have been published in such
journals as Cancer Research, the Journal of Clinical Oncology,
American Journal of Hematology Oncology, New England Journal
of Medicine, and the Journal of the American Medical Association.
In addition to serving on the NCCN Board of Directors for 2008, he has
also been the recipient of numerous honors and awards, most recently
including Best Doctors in America 2007-2008, Castle Connolly Medical
Best Doctors 2006 and the 2006 Gold Medal Award from King Edward Medical
College Alumni Association of North America (KEMCAANA).
Dr. Jahanzeb received his medical degree with high honors from King
Edward Medical College at the University of Punjab in Lahore, Pakistan.
He completed his internship and residency at the New Britain General
Hospital of the University of Connecticut in New Britain, Connecticut.
Dr. Jahanzeb went on to complete his Fellowship in Hematology and
Oncology at Washington University, Department of Internal Medicine in
St. Louis, Missouri, where he later served as an Assistant Professor of
Medicine in the Division of Oncology for more than two years. He also
spent nearly seven years in Florida where, as Research Director at the
Comprehensive Cancer Center at Boca Raton, he was actively involved in
developing and conducting clinical trials. Dr. Jahanzeb also served as
Assistant Professor of Biomedical Research at Florida Atlantic
University.
About Aptium Oncology
Aptium Oncology has 25 years of experience managing outpatient oncology
services at leading medical institutions throughout the United States.
Aptium Oncology is a pioneer in designing, building and managing
comprehensive cancer centers, with a steadfast vision to transform
cancer care environments by bringing every necessary service to one
central place. The intent of this single place is to help patients
achieve longer, better lives. Aptium Oncology's corporate headquarters
are located in Los Angeles, Calif. For more information, visit www.aptiumoncology.com.
Post Comment: Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1Ib3JyLUNvdXAtTG92ZS1TaW5nLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.